Ninety Days
1164 Words
Ninety days sounds like time until you put it on a calendar.
Then it becomes squares.
Thirteen weeks.
Three months.
A season.
A countdown polite enough to look ordinary.
Adrian stared at the projected model without speaking.
The federal agent began making calls.
Naomi began checking assumptions.
I began looking for ways the model could be wrong.
Not because he was Adrian.
Because he was my patient.
I repeated that until it sounded true enough to work.
“The curve assumes no effective intervention,” I said. “We already have partial response.”
Adrian looked at me.
“From you.”
“From a phase-active protein in my blood.”
“Same distinction?”
“Yes.”
He nodded.
No argument.
Progress measured in millimeters.
We tested my isolated proteins against five Silverfade samples.
All slowed.
Adrian’s responded most strongly.
Eli’s second.
The other cases weakly but measurably.
Naomi mapped the response against mate-bond receptor architecture.
“This should not exist after rejection,” she said.
“Neither should half the things in my childhood file.”
The federal agent wanted to transfer my sample to a government lab.
I refused.
She threatened an emergency warrant.
I invited her to obtain one.
Adrian’s eyes followed the argument through the glass.
Finally he said, “Cascade will fund the work here.”
The number he did not say yet sat behind the offer anyway.
HelixNova was successful by research-lab standards, which meant we were always one delayed grant and one failed trial away from becoming a cautionary story. Fifty million dollars could buy sequencers, isolation capacity, staff, legal protection, and time for patients who did not have any.
It could also buy influence over every decision that followed.
That was why the offer frightened me more than an obvious threat would have.
“No.”
He blinked.
“I have not even stated terms.”
“You are an Alpha with a dying wolf. There will be terms.”
“Research support. No ownership.”
“Put it in writing.”
“I will.”
“Independent counsel.”
“Yes.”
“Open publication of any broadly effective treatment.”
Naomi looked at me over the top of her tablet.
She knew what I was asking him to surrender.
A proprietary cure for a disease spreading through the most powerful packs in the country could be worth billions.
I was asking a dying Alpha to promise that if we found one, nobody would own the door.
His pause lasted one second.
“Agreed.”
The federal agent looked appalled.
“You cannot promise open release of biological countermeasures during a federal emergency.”
I looked at her.
“Watch me.”
By afternoon, Eli deteriorated again.
The microdose had bought hours, not a cure.
His mother signed consent for a second ex vivo-guided infusion using a purified fraction from my voluntary sample.
I sat with her before she signed.
“This may help,” I said. “It may also teach the disease how to adapt.”
“What happens if we do nothing?”
“His wolf signal will probably reach zero.”
“And then?”
“His organs may fail.”
She closed her eyes.
“Would you do it?”
The question was a trap even when asked with love.
“My choice would not be yours.”
She opened her eyes.
“Then tell me what you know.”
So I did.
No persuasion.
No false certainty.
When she signed, it was her decision.
The infusion raised Eli’s wolf signal to twelve percent.
Twelve percent was still catastrophic by any normal standard.
But the curve had stopped falling.
Naomi printed the trend and taped it beside the first graph from six hours earlier.
Downward line.
Flat line.
The difference between dying now and having enough time to ask another question.
I had built my career on questions other doctors had stopped asking.
Silverfade was about to test whether that stubbornness was science or merely personality.
He woke long enough to ask for water.
Then he whispered Rook’s name again.
Across the hall, Adrian watched.
“You are good at that,” he said later.
“At what?”
“Letting people make decisions you think may hurt them.”
I looked at him.
The subtext was not subtle.
“You mean unlike you.”
“Yes.”
No defense.
I hated how much easier honesty made him to be around.
“Do not turn self-awareness into penance theater,” I said.
“I am trying not to.”
“Try quieter.”
He almost smiled.
My phone buzzed.
Unknown number.
A video file.
Naomi isolated it before opening.
Patient Zero appeared in darkness again.
“You used the blood,” he said.
I felt cold.
“How do you know?”
He ignored the question.
“Do not become their cure.”
“I am not interested in slogans.”
“Then take data. Silverfade learns.”
“We know.”
“It learns you fastest.”
The distortion around his face flickered.
“Every dose buys time and teaches the next attack how to survive you.”
Naomi recorded everything.
“How do we stop adaptation?” she asked.
Patient Zero turned toward her voice.
“Find what they took before they built the disease.”
“What did they take?” I asked.
“Your wolf.”
My chest tightened.
“My wolf died eight years ago.”
“No.”
The answer came too quickly.
“They taught her to hide.”
The dormant pressure under my ribs slammed hard enough to make me grab the desk.
Adrian stood inside Isolation Three.
“Dr. Hart?”
I raised a hand.
Fine.
Not fine.
Patient Zero continued.
“Your blood is not the cure. It is the map.”
“To what?”
“Genesis.”
The connection broke.
Naomi turned to me.
“Project name?”
“I have never heard it.”
Adrian had.
I saw it in his face.
“What?” I asked.
He looked at the floor.
“My father used the word once.”
“When?”
“During the last argument we had before he disappeared.”
My pulse accelerated.
“What did he say?”
Adrian looked at me through the glass.
“He said Cascade had forgotten what Genesis was built to protect.”
“Built?”
“I thought he meant the pack.”
“You were wrong.”
“Yes.”
The federal agent’s tablet chimed.
A government warrant had been approved for all Silverfade materials.
At the same moment, Vale legal sent Adrian a proposed emergency research agreement.
The headline number glowed at the top.
$50,000,000.
I looked at Adrian.
“You said no ownership.”
His face hardened as he read the terms.
“I did.”
“Your lawyers disagree.”
“Then they are about to have a bad afternoon.”
- Writer
- chap_listContents
- likeADD